Legal & General Group Plc acquired a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 18,873,343 shares of the company’s stock, valued at approximately $2,425,225,000. Merck KGaA accounts for approximately 0.5% of Legal & General Group Plc’s investment portfolio, making the stock its 29th biggest holding. Legal & General Group Plc owned about 14.60% of Merck KGaA at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of MKGAF. Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in shares of Merck KGaA in the second quarter worth about $942,087,000. Bank of Nova Scotia purchased a new stake in shares of Merck KGaA during the 2nd quarter valued at about $281,696,000. Danske Bank A S acquired a new position in Merck KGaA during the 2nd quarter worth approximately $276,535,000. The Manufacturers Life Insurance Company acquired a new position in Merck KGaA during the 2nd quarter worth approximately $266,403,000. Finally, Cullen Capital Management LLC purchased a new position in Merck KGaA in the 2nd quarter worth approximately $259,158,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Stock Up 0.1%
Shares of OTCMKTS:MKGAF opened at $163.45 on Tuesday. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56. The company has a 50 day moving average of $162.78 and a two-hundred day moving average of $148.59. The company has a market capitalization of $21.12 billion, a price-to-earnings ratio of 24.95 and a beta of 0.96.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
- Five stocks we like better than Merck KGaA
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
